| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Selisistat |
|
49843-98-3 |
詳細(xì)
|
| Pioglitazone hydrochloride |
|
112529-15-4 |
詳細(xì)
|
| STS-E412 |
|
1609980-39-3 |
詳細(xì)
|
| PF 06700841-15 |
|
2140301-96-6 |
詳細(xì)
|
| Vismodegib |
|
879085-55-9 |
詳細(xì)
|
| Tradipitant |
|
622370-35-8 |
詳細(xì)
|
| Dacomitinib |
|
1110813-31-4 |
詳細(xì)
|
| CGS 21680 hydrochloride |
|
124431-80-7 |
詳細(xì)
|
| 3-[[4-methyl-2-nitro-5-(3-pyridyl)phenyl]sulfamoyl]benzoic acid |
|
1612888-66-0 |
詳細(xì)
|
| Roflumilast |
|
162401-32-3 |
詳細(xì)
|
| Enasidenib |
|
1446502-11-9 |
詳細(xì)
|
| Levomilnacipran hydrochloride |
|
175131-60-9 |
詳細(xì)
|
| 1-{4-[(2S)-6,15-dibromo-13-chloro-4-azatricyclo[9.4.0.03,]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl]piperidin-1-yl}-2-(piperidin-4-yl)ethan-1-one |
|
1099484-75-9 |
詳細(xì)
|
| Ibuprofen |
|
15687-27-1 |
詳細(xì)
|
| 4-[[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]-1,3-benzothiazol-6-yl]oxy]-N-methyl-pyridine-2-carboxamide;hydrate;dihydrochloride |
|
2222138-27-2 |
詳細(xì)
|
| BT-11 |
|
1912399-75-7 |
詳細(xì)
|
| CNF-2024 |
|
848695-25-0 |
詳細(xì)
|
| SLx-4090 |
|
913541-47-6 |
詳細(xì)
|
| GLPG-1690 |
2-[（2-乙基-6-{4- [2-（3-羥基氮雜環(huán)丁烷-1-基）-2-氧代乙基]哌嗪-1-基}-8-甲基咪唑并[1,2-a]-吡啶）（甲基）氨基]-4-（4-氟苯基）-1,3-噻唑-5-甲腈 |
1628260-79-6 |
詳細(xì)
|
| Etoricoxib |
|
202409-33-4 |
詳細(xì)
|
| 2-[(1S)-1-aminoethyl]-5-chloro-3-phenyl-3,4-dihydroquinazolin-4-one |
|
1420627-35-5 |
詳細(xì)
|
| INCB-047775 |
|
1430056-54-4 |
詳細(xì)
|
| Apitolisib |
|
1032754-93-0 |
詳細(xì)
|
| BLU-667 |
|
2097132-94-8 |
詳細(xì)
|
| tenofovir alafenamide |
|
379270-37-8 |
詳細(xì)
|
| TGX-221 |
|
663619-89-4 |
詳細(xì)
|
| EPZ015866 |
|
1616391-87-7 |
詳細(xì)
|
| Altiratinib |
|
1345847-93-9 |
詳細(xì)
|
| BGC-20-1531 |
|
1186532-61-5 |
詳細(xì)
|
| Ambrisentan |
|
177036-94-1 |
詳細(xì)
|
| CC-220 |
|
1323403-33-3 |
詳細(xì)
|
| Volinanserin |
|
139290-65-6 |
詳細(xì)
|
| Vandetanib |
|
443913-73-3 |
詳細(xì)
|
| GSK-2269557 |
|
1254036-77-5 |
詳細(xì)
|
| 4-amino-5-chloro-N-[1-(3-methoxypropyl)-4-piperidyl]-2,3-dihydrobenzofuran-7-carboxamide;succinic acid |
|
179474-85-2 |
詳細(xì)
|
| Mozavaptan |
|
137975-06-5 |
詳細(xì)
|
| Rupintrivir |
|
223537-30-2 |
詳細(xì)
|
| A-769662 |
|
844499-71-4 |
詳細(xì)
|
| Voriconazole |
|
137234-62-9 |
詳細(xì)
|
| ND-646 |
|
1434639-57-2 |
詳細(xì)
|
| azd-8186 |
|
1627494-13-6 |
詳細(xì)
|
| BMS-387032 |
|
345627-80-7 |
詳細(xì)
|
| Linagliptin |
|
668270-12-0 |
詳細(xì)
|
| Buparlisib |
|
944396-07-0 |
詳細(xì)
|
| Lansoprazole |
|
103577-45-3 |
詳細(xì)
|
| Canagliflozin hemihydrate |
|
928672-86-0 |
詳細(xì)
|
| Bosentan hydrate |
|
157212-55-0 |
詳細(xì)
|
| Raltegravir potassium |
|
871038-72-1 |
詳細(xì)
|
| Axitinib |
|
319460-85-0 |
詳細(xì)
|
| 2-[[6-[(3R)-3-amino-1-piperidyl]-3-methyl-2,4-dioxo-pyrimidin-1-yl]methyl]benzonitrile;benzoic acid |
|
850649-62-6 |
詳細(xì)
|
| Sulfo-SMCC sodium |
|
92921-24-9 |
詳細(xì)
|
| ASLAN-002 |
|
1025720-94-8 |
詳細(xì)
|
| 5-{[6-chloro-5-(1-methyl-1H-indol-5-yl)-1H-1,3-benzodiazol-2-yl]oxy}-2-methylbenzoic acid |
|
1219739-36-2 |
詳細(xì)
|
| 3-(difluoromethyl)-1-methyl-5-[3-(trifluoromethyl)phenoxy]-1H-pyrazole-4-carboxylic acid |
|
1369490-06-1 |
詳細(xì)
|
| Esomeprazole magnesium trihydrate |
|
217087-09-7 |
詳細(xì)
|
| bcx-4430 |
|
249503-25-1 |
詳細(xì)
|
| Ivacaftor |
|
873054-44-5 |
詳細(xì)
|
| 5(R)-Deuteropioglitazone |
|
1259828-75-5 |
詳細(xì)
|
| JNJ-7777120 |
|
459168-41-3 |
詳細(xì)
|
| OTX-015 |
|
202590-98-5 |
詳細(xì)
|
| Dabigatran etexilate |
|
211915-06-9 |
詳細(xì)
|
| Odanacatib |
|
603139-19-1 |
詳細(xì)
|
| VX-661 |
|
1152311-62-0 |
詳細(xì)
|
| Sorafenib tosylate |
|
475207-59-1 |
詳細(xì)
|
| Bicalutamide |
|
90357-06-5 |
詳細(xì)
|
| Ceritinib |
|
1032900-25-6 |
詳細(xì)
|
| Encenicline hydrochloride |
|
550999-74-1 |
詳細(xì)
|
| Saroglitazar magnesium |
|
1639792-20-3 |
詳細(xì)
|
| IPI-145 |
|
1201438-56-3 |
詳細(xì)
|
| Sapanisertib |
|
1224844-38-5 |
詳細(xì)
|
| BMS-986142 |
|
1643368-58-4 |
詳細(xì)
|
| MYK-461 |
|
1642288-47-8 |
詳細(xì)
|
| ABT-494 enantiomer |
|
1310726-59-0 |
詳細(xì)
|
| GSK-180 |
|
1799725-26-0 |
詳細(xì)
|
| E-7046 |
|
1369489-71-3 |
詳細(xì)
|
| (7S)-5'-chloro-3-[(1R)-1-(4-chlorophenyl)ethyl]-1',2',3,4,5,6-hexahydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indole]-2',5-dione |
|
1630979-55-3 |
詳細(xì)
|
| Encorafenib |
|
1269440-17-6 |
詳細(xì)
|
| Dasatinib |
|
302962-49-8 |
詳細(xì)
|
| 2-[(e)-2-phenyldiazen-1-yl]propanedinitrile |
|
6017-21-6 |
詳細(xì)
|
| Atazanavir sulfate |
|
229975-97-7 |
詳細(xì)
|
| flibanserin |
|
167933-07-5 |
詳細(xì)
|
| Pritelivir |
|
348086-71-5 |
詳細(xì)
|
| Pictilisib |
|
957054-30-7 |
詳細(xì)
|
| GTx-011 |
|
1446321-46-5 |
詳細(xì)
|
| ABBV-075 |
|
1445993-26-9 |
詳細(xì)
|
| GSK-516 |
|
317318-70-0 |
詳細(xì)
|
| WZ-3146 |
|
1214265-56-1 |
詳細(xì)
|
| (2S,3S,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-ol |
（2S，3S，11bR）-9,10-二甲氧基-3-（2-甲基丙基）-1H，2H，3H，4H，6H，7H，11bH吡啶并[2,1-α]異喹啉-2-醇 |
862377-27-3 |
詳細(xì)
|
| Alpelisib |
|
1217486-61-7 |
詳細(xì)
|
| 2-[(1R)-3-(diisopropylamino)-1-phenyl-propyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate;fumaric acid |
|
286930-03-8 |
詳細(xì)
|
| (2S,3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-ol |
（2S,3R,11bR）-9,10-二甲基氧基-3-（2-甲基丙基）-1H,2H,3H,4H,6H,11bH-吡啶[2,1-a]異喹啉-2-醇 |
924854-60-4 |
詳細(xì)
|
| Grapiprant |
|
415903-37-6 |
詳細(xì)
|
| BAL-27862 |
|
798577-91-0 |
詳細(xì)
|
| Eslicarbazepine acetate |
|
236395-14-5 |
詳細(xì)
|
| JH-II-127 |
|
1700693-08-8 |
詳細(xì)
|
| PF-06700841 |
|
1883299-62-4 |
詳細(xì)
|
| R-121919 |
|
195055-03-9 |
詳細(xì)
|
| GSK-1482160 |
|
1001389-72-5 |
詳細(xì)
|
| 4-ethyl-N-{3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl}-3-(2-{pyrazolo[1,5-a]pyrimidin-6-yl}ethynyl)benzamide |
|
1429617-90-2 |
詳細(xì)
|
| SQ-609 |
|
627052-25-9 |
詳細(xì)
|